Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

NCT01414075 ·Status: COMPLETED ·Phase: PHASE2

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

NCT01887600 ·Status: COMPLETED ·Phase: PHASE3

Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis

NCT00761657 ·Status: COMPLETED ·Phase: PHASE2

A Study of Lanabecestat in Participants With Severe Kidney Impairment Compared to Healthy Participants

NCT03545087 ·Status: WITHDRAWN ·Phase: PHASE1

Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease

NCT06725810 ·Status: RECRUITING ·Phase: PHASE4

Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04925011 ·Status: UNKNOWN ·Phase: PHASE3

A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function

NCT02965040 ·Status: COMPLETED ·Phase: PHASE1

Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome

NCT07116239 ·Status: NOT_YET_RECRUITING ·Phase: NA

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

NCT01630889 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy

NCT05834738 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

NCT01999582 ·Status: COMPLETED ·Phase: PHASE2

A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With Anemia

NCT02780726 ·Status: COMPLETED ·Phase: PHASE3

Single-Dose PK Study of GBT440 in Subjects With Renal Impairment

NCT03161015 ·Status: COMPLETED ·Phase: PHASE1

Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

NCT04621331 ·Status: WITHDRAWN ·Phase: PHASE3

Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

NCT02202512 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

NCT00733265 ·Status: COMPLETED ·Phase: PHASE1

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)

NCT00501046 ·Status: COMPLETED ·Phase: PHASE3

A Renal Impairment Study for PF-04965842

NCT03660241 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

NCT00293202 ·Status: TERMINATED ·Phase: PHASE2

Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT00414440 ·Status: COMPLETED ·Phase: PHASE4

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

NCT04154670 ·Status: COMPLETED ·Phase: PHASE1

Study of FG-4592 in Subjects With Chronic Kidney Disease in China

NCT01599507 ·Status: COMPLETED ·Phase: PHASE2

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

NCT02629224 ·Status: COMPLETED ·Phase: PHASE1

Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.

NCT02866214 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

NCT03054350 ·Status: COMPLETED ·Phase: PHASE2